Health
FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer – FDA.gov
FDA authorized marketing of the first device that uses artificial intelligence to detect lesions in the colon during a colonoscopy.
For Immediate Release:
April 09, 2021
Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning to assist clinicians in detecting lesions (such as polyps or suspected tumors) in the colon in real time during a colonoscopy.
Artificial intelligence has the potential to transform health care to better assist health care providers and improve patient care. When AI is combined with traditional…
-
General18 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News22 hours agoBrisbane rising on global rankings, but still behind southern capitals
-
Noosa News22 hours agoWest End icon closes doors
-
General18 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire